Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-142-3 | CAS number: 103-76-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames test: negative
HPRT test: negative
Chromosome aberration: negative
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- May 1983/ Revised Draft, March 1996
- Deviations:
- yes
- Remarks:
- (2-aminoanthracene was the only used positive control in experiments with metabolic activation)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Version / remarks:
- Date of deletion: 21 July 1997 (Method merged with TG 471)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- December 1992
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- - Batch No.: 25-7626
- storage: room temperature - Target gene:
- his and trp operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: defective excision repair system
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix from Aroclor 1254 treated male Sprague-Dawley rats.
- Test concentrations with justification for top dose:
- 0, 20, 100, 500, 2500 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: good solubility - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: with S-9 mix: all strains 2-aminoanthracene; without S-9 mix: strains TA100, TA1535: N-methyl-N'-nitro-N-nitrosoguanidine; TA98: 4-nitro-o-phenylendiamine; TA1537: 9-aminoacridine; E.coli WP2 uvrA: N-ethyl-N'-nitro-N-nitrosoguanidine.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 - 72 h
NUMBER OF REPLICATIONS: 3
METHOD OF APPLICATION: standard plate test
DURATION
- Exposure duration: 48 - 72 h
NUMBER OF REPLICATIONS: 3 - Evaluation criteria:
- The test chemical is considered positive in this assay if the following criteria are met: A dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S-9 mix or after adding a metabolizing system.
A test substance is generally considered non-mutagenic in this test if: The number of revertants for all tester strains were within the historical negative control range under all experimental conditions in two experiments carried out independently of each other. - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A slight decrease of revertants was occasionally observed from 2500 µg/plate onwards.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A slight decrease of revertants was occasionally observed from 2500 µg/plate onwards.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A slight decrease of revertants was occasionally observed from 2500 µg/plate onwards.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A slight decrease of revertants was occasionally observed from 2500 µg/plate onwards.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No Test substance precipitation was found. - Conclusions:
- neagtive Ames test
- Executive summary:
A study according to OECD TG 471 was conducted to assess the in vitro gene mutation potential of the test item in different bacteria strains (TA 1537, TA 1535, TA 98, TA 100 and E. coli WP uvrA). In the preincubation method bacteria were preincubated for 20 min with the test item using concentrations of 20, 100, 500, 2500 and 5000 µg/plate. Water was used as solvent control. Afterwards, bacterial were plates and exposed for 48 to 72 h. In the standard plate test the exposure duration was 48 to 72 hours as well. Incubation was done in the presence and in the absence of a metabolizing system (S9-Mix from Aroclor-1254 treated male rats). With regard to cytotoxicity, a slight decrease of revertants was occasionally observed from 2500 µg/plate onwards. No genotoxicity was observed neither in presence nor absence of S9-mix. The positive controls induced a significant increase in mutation frequency.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 4 February 2016 - 12 May 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 28 July 2015
- Deviations:
- yes
- Remarks:
- increase of the seeded cell number and increase of the seeded cells during the individual passages of the test
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- August 1998
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell transformation assay
- Specific details on test material used for the study:
- - Batch: B1057 (vom 13.12.2015)
- storage conditions: room temperature - Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Cell cycle length, doubling time: about 12-16 hours
- Modal number of chromosomes: 20
MEDIA USED
- Type and identity of media including CO2 concentration if applicable: Ham´s F12 medium containing stable glutamine and hypoxanthine supplemented with 10% fetal calf serum, 1% (v/v) penicillin/streptomycin, 1% (v/v) amphotericine B; cells were grown with 5% CO2 at 37°C
- Properly maintained: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- S9-Mix prepared from Wistar rats
- Test concentrations with justification for top dose:
- In the pretest for toxicity based on the purity and the molecular weight of the test substance 1400 μg/mL (approx. 10 mM) was used as top concentration both with and without S9 mix at 4-hour exposure time. In addition, precipitation of the test substance was not observed in the stock solution (test group: 1400 μg/mL). A slight pH shift was observed at the highest required concentration prior to testing. Therefore, the pH of the stock solution was adjusted to a physiological value prior to application using small amounts of 32% (w/v) HCl.
According to an initial range-finding cytotoxicity test for the determination of the experimental doses, the following concentrations were tested.
1st Experiment
without S9 mix
0; 43.8; 87.5; 175.0; 350.0; 700.0; 1400.0 μg/mL
with S9 mix
0; 43.8; 87.5; 175.0; 350.0; 700.0; 1400.0 μg/mL
2nd Experiment
with S9 mix
0; 62.5; 125.0; 250.0; 500.0; 1000.0; 1400.0 μg/mL
3rd Experiment
without S9 mix
0; 62.5; 125.0; 250.0; 500.0; 1000.0; 1400.0 μg/mL - Vehicle / solvent:
- Due to the good solubility of the test substance in water, the aqueous culture medium (Ham's F12) was selected as vehicle.
- Untreated negative controls:
- yes
- Remarks:
- cell culture medium without test item
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium /in agar
- Cell density at seeding: 20x10E6 cells/40 mL
DURATION
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 7-9 days
- Selection time: 6-7 days
- Fixation time: at the end of the selection period, from day 16
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency, absolute and relative cloning efficiencies (%) were calculated for each test group - Evaluation criteria:
- The HPRT assay is considered valid if the following criteria are met:
- absolute cloning efficiencies of the negative/vehicle controls should not be less than 50% (with and without S9 mix)
- Background mutant frequency in the negative/vehicle controls should be within historical negative control data range (95% control limit).
- positive controls both with and without S9 mix should induce a distinct, statistically significant increase in mutant frequencies in the expected range
The test substance is considered to be clearly positive if all following criteria are met:
- statistically significant increase in mutant frequencies
- dose-related increase in mutant frequencies
- corrected mutation frequencies exceeds both the concurrent negative/vehicle control value and the range of historical negative control data (95% control limit) - Statistics:
- An appropriate statistical trend test (MS EXCEL function RGP) was performed to assess a possible dose-related increase of mutant frequencies. The dependent variable was the corrected mutant frequency and the independent variable was the concentration. The trend was judged as statistically significant whenever the one-sided p-value (probability value) was below 0.05 and the slope was greater than 0. In addition, a pair-wise comparison of each test group with the vehicle control group was carried out using one-sided Fisher's exact test with Bonferroni-Holm correction.
However, both, biological and statistical significance are considered together - Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Cytotoxic effects, as indicated by clearly reduced cloning efficiencies of about or below 20% of the respective negative control values were not observed in all experiments in the absence and presence of S9 mix. Osmolality and pH values were not influenced by test substance treatment. No precipitation in culture medium was observed up to the highest applied test substance concentration.
- Conclusions:
- negative HPRT assay
- Executive summary:
In a study according to OECD TG 476, the in vitro gene mutation potential of the test substance in mammalian CHO cells was assessed. After seeding, cells were exposed in the first experiment to concentrations of 43.8, 87.5, 175, 350, 700 or 1400 µg/mL with or without S9-mix freshly prepared from Wistar rats. In the second and third experiment concentrations of 62.5, 125, 250, 500, 1000 and 1400 µg/mL were used. As vehicle and negative control, cell culture medium was utilized. After an exposure time of 4 hours, medium was removed and cell were grown in normal cell culture medium for 7 to 9 days, followed by incubation in selection medium for a period of 6 to 7 days. At the end of the selection period, cells were fixed and cloning efficiency was determined. Positive controls (ethylmethanesulphonate without S9-mix and 7,12-dimethylbenzanthracene with metabolic activation) proved to be valid under the test conditions chosen. For the test substance, no cytotoxic effects were observed in all experiments and no genotoxicity could be detected neither in the presence nor absence of S9-mix.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 26 Sep 2014
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Version / remarks:
- August 1998
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: chromosome aberration test
- Specific details on test material used for the study:
- - batch: B1057 (vom 13.12.2015)
- storage conditions: room temperature - Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Suitability of cells: high plating efficiency (>90%)
- Cell cycle length, doubling time: about 12-14 hours
- Modal number of chromosomes: 22
MEDIA USED
- Type and identity of media including CO2 concentration: MEM medium containing a L-glutamine source supplemented with 10% (v/v) fetal calf serum, 1% (v/v) penicillin/streptomycin (10000µg/mL), 1% (v/v) amphotericin B ( 250 µg/mL); incubation at 37°C, 5% CO2
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes - Cytokinesis block (if used):
- 100 µL colcemide
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix from phenobarbital and beta-naphthoflavone induced rats
- Test concentrations with justification for top dose:
- In the pretest for toxicity based on the purity and the molecular weight of the test substance 1350 μg/mL (approx. 10 mM) was used as top concentration. In the pretest the pH value was not relevant influenced by the addition of the test substance preparation to the culture medium at the concentrations tested. However, a slight pH shift was observed at the highest applied concentration prior to testing. Therefore, the pH of the stock solution was adjusted to a physiological value prior to application using small amounts of 32% (w/v) HCl. In addition, no test substance precipitation in culture medium was observed up to the highest required concentration of 1350 μg/mL.
1st Experiment
4-hour exposure, 18-hour sampling time, without S9 mix (failed acceptance criteria)
0; 43.8; 87.5; 175; 350; 700; 1400 μg/mL
4-hour exposure, 18-hour sampling time, with S9 mix
0; 43.8; 87.5; 175; 350; 700; 1400 μg/mL
2nd Experiment
4-hour exposure, 18-hour sampling time, without S9 mix
0; 175; 350; 700; 1400 μg/mL
3rd Experiment
18-hour exposure, 18-hour sampling time, without S9 mix
0; 43.8; 87.5; 175; 350; 700; 1400 μg/mL
4-hour exposure, 28-hour sampling time, with S9 mix
0; 87.5; 175; 350; 700; 1400 μg/mL
4th Experiment
18-hour exposure, 18-hour sampling time, without S9 mix
0; 31.3; 62.5; 125; 250; 500; 1000 μg/mL
4-hour exposure, 28-hour sampling time, with S9 mix
0; 125; 250; 500; 1000; 1400 μg/mL
5th Experiment
4-hour exposure, 28-hour sampling time, with S9 mix
0; 400; 600; 800, 1000; 1200; 1400 μg/mL - Vehicle / solvent:
- - Justification for choice of solvent/vehicle: Due to the good solubility of the test substance in water, culture medium (MEM: Minimal
Essential Medium) was selected as most suitable vehicle. - Untreated negative controls:
- yes
- Remarks:
- culture medium without test item
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
- Cell density at seeding: 3-8x10E4 cells per culture, depending on the schedule
DURATION
- Exposure duration: 4 hours (Exp. I +II), 18 hours (Exp.II+IV) without S9-Mix or 4 hours with S9-Mix
- Recovery time: 14 hours (Exp.I+II) without S9-Mix or 24 hours (Exp.III,IV,V) with S9-Mix
- Sampling time: 18 hours or 28 hours for Exp. II,IV,V with S9-Mix
- Fixation time: 2 - 3 hours prior to cell harvest, 100 μL colcemide added to in order to arrest mitosis in the metaphase, followed by hypotonic treatment (20 min) and addition of fixative
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: cells seeded on Quadriperm dishes; these slides were stained with 7.5% (v/v) Giemsa/Titrisol solution pH 7.2 for 10 min
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE: 150 consecutive well-spread metaphases of each culture (in total 300 metaphases
per test group) analyzed for structural chromosome aberrations on coded slides for all test groups
DETERMINATION OF CYTOTOXICITY:
- Method: mitotic index
In general, 1000 cells per culture were counted for the occurrence of mitotic cells. All cells being in the pro-, meta-, ana- or telophase were considered as mitotic cells. The mitotic index was determined at least for the vehicle controls and the test groups that were evaluated for cytogenetic damage
OTHER EXAMINATIONS:Changes in the number of chromosomes by whole chromosome sets
- Determination of polyploidy:
- Determination of endopolyploidy:Tetraploid metaphases with so-called diplo-chromosomes (products of endomitotic chromosome reduplication) - Evaluation criteria:
- The test substance is considered as clearly positive if the following criteria are met:
- Statistically significant increase in the number of metaphase cells containing structural chromosome aberrations (excl. gaps)
- Dose-related increase in the number of metaphase cells containing structural chromosome aberrations (excl. gaps)
- Number of aberrant metaphase cells (excl. gaps) exceeded both the concurrent vehicle control value and the range of historical negative control data (95% control limit)
The test substance is considered as clearly negative if the following criteria are met:
-Neither a statistically significant nor dose-related increase in the number of metaphase cells containing structural chromosome aberrations (excl. gaps) under any experimental condition
-Number of aberrant metaphase cells (excl. gaps) in all treated test groups was close to the concurrent vehicle control value and within the range of our historical negative control data (95% control limit) - Statistics:
- The statistical evaluation of the data was carried out using a suitable software system
(Metafer4, Metasystems, Germany). The proportion of metaphases with aberrations was calculated for each test group. A comparison of each test group with the respective vehicle control group was carried out using Fisher's exact test (one-sided) for the hypothesis of equal proportions. However, both, biological and statistical significance were considered together. - Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- Aberration rates slightly exceeding the historical control data range and/or statistically significant increased values were obtained in single test groups which were considered biologically irrelevant.
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- - no biologically relevant increase in the number of cells with changes in the number of chromosomes was demonstrated either without S9 mix or after the addition of a metabolizing system
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no influence
- Effects of osmolality: no influence
- Precipitation: not observed
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Mitotic index: According to the results of the determination of the mitotic index, no relevant suppression of the mitotic activity was observed under any of the experimental conditions up to the highest scorable concentration.
- Relative Population doubling: no growth inhibition was observed under any experimental condition when tested up to the highest required concentration - Conclusions:
- negative in vitro CA test
- Executive summary:
For the assessment of structural chromosomal aberrations and aneugenic activity, a study according OECD TG 476 was performed in vitro. Five experiments using mammalian V79 cells were performed selecting different exposure times (4 and 18 hours) and sampling times (18 and 28 hours). The highest concentration on all experiments used was 1400 µg/mL. For metabolic activation, liver S9 mix from phenobarbital and beta-naphthoflavone induced rats was used. At least 300 metaphases for each test group were analyzed for chromosomal aberrations. The increase in the frequencies of structural chromosome aberrations induced by the positive control substances ethylmethanesulphonate and cyclophosphamide clearly demonstrated the sensitivity of the test system and/or the metabolic activity of the S9 mix employed. No relevant increase in the frequency of cells containing numerical chromosome aberrations was demonstrated under the experimental conditions described neither in absence nor presence of metabolic activation. Aberration rates slightly exceeding the historical control data range or statistically significant increased values were obtained in single test groups which were considered biologically irrelevant.
Referenceopen allclose all
Standard plate test:
Dose (µg/plate) | TA1535 | TA100 | TA1537 | TA98 | E coli. WP2 uvrA | |||||
|
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
0 |
20±2 |
21±2 |
140±17 |
151±14 |
14±1 |
16±2 | 32±5 | 39±4 | 32±2 | 42±5 |
20 | 20±1 | 21±1 | 154±7 | 151±16 | 11±2 | 13±2 | 33±4 | 41±7 | 33±3 | 37±3 |
100 | 19±1 | 20±2 | 145±9 | 147±12 | 10±3 | 10±1 | 32±3 | 43±7 | 31±1 | 39±3 |
500 | 22±2 | 20±2 | 147±19 | 139±11 | 10±0 | 10±1 | 34±7 | 29±2 | 29±1 | 38±2 |
2500 | 21±1 | 13±2 | 127±6 | 136±7 | 11±1 | 9±1 | 28±3 | 27±4 | 27±5 | 35±4 |
5000 | 20±1 | 11±1 | 140±6 | 140±6 | 8±2 | 11±3 | 31±3 | 22±5 | 27±3 | 33±3 |
2-AA | - | 223±13 | - | 1431±6 | - | 118±4 | - | 1005±9 | - | 266±37 |
MNNG | 1119±105 | - | 1025±56 | - | - | - | - | - | - | - |
AAC | - | - | - | - | 307±4 | - | - | - | - | - |
NPD | - | - | - | - | - | - | 1011±7 | - | - | - |
ENNG | - | - | - | - | - | - | - | - | 512±13 | - |
Mean ± SD
Preincubation test:
Dose (µg/plate) | TA1535 | TA100 | TA1537 | TA98 | E. coli WP2 uvrA | ||||||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
0 | 21±3 | 22±4 | 140±6 | 160±1 | 10±1 | 12±0 | 31±1 | 45±1 | 36±1 | 50 ± 2 | |
20 | 19±3 | 18±3 | 144±11 | 158±3 | 11±2 | 11±1 | 29±3 | 45±2 | 34±2 | 52 ± 6 | |
100 | 21±2 | 20±4 | 142±7 | 153±8 | 10±1 | 9±2 | 24±4 | 40±2 | 31±3 | 47 ± 2 | |
500 | 21±2 | 17±2 | 160±11 | 155±5 | 10±2 | 12±2 | 26±1 | 43±3 | 34±4 | 44 ± 4 | |
2500 | 17±2 | 16±1 | 169±10 | 162±8 | 9±2 | 9±3 | 29±5 | 38±2 | 31±5 | 44 ± 6 | |
5000 | 16±2 | 10±2 | 158±16 | 161±1 | 8±2 | 9±2 | 26±2 | 45±2 | 32±5 | 42 ± 6 | |
2-AA | - | 149±11 | - | 1484±45 | - | 174±23 | - | 1226±163 | - | 223 ±25 | |
MNNG | 1644±231 | - | 2034±58 | - | - | - | - | - | - | - | |
AAC | - | - | - | - | 712±11 | - | - | - | - | - | |
NPD | - | - | - | - | - | - | 1281±64 | - | - | - | |
ENNG | - | - | - | - | - | - | - | - | 670±44 | - |
Mean ± SD
2-AA: 2-aminoanthracene;
MNNG; N-methyl-N-nitro-N-nitrosoguanidine
ENNG; N-ethyl-N-nitro-N-nitrosoguanidine
NPD: 4-nitro-o-phenylendiamine
AAC: 9-aminoacridine chloride monohydrate
Table 1: Summary of results- experimental parts without S9 mix
Exp. |
Exposure Period [h] |
Test groups [µg/mL] |
S9 mix |
Prec.* |
Genotoxicity** MF corr. [per 10E6 cells] |
Cytotoxicity*** CE1 [%] |
Cytotoxicity*** CE2 [%] |
1 |
4 |
Negative control |
- |
n.d. |
6.21 |
100 |
100 |
|
|
43.8 |
- |
- |
1.47 |
107.8 |
105.6 |
|
|
87.5 |
- |
- |
0.30 |
101.6 |
102.5 |
|
|
175.0 |
- |
- |
0.00 |
105.4 |
113.7 |
|
|
350.0 |
- |
- |
0.59 |
95.7 |
105.0 |
|
|
700.0 |
- |
- |
6.67 |
104.0 |
102.5 |
|
|
1400 |
- |
- |
1.03 |
97.8 |
90.7 |
|
|
Positive control(1) |
- |
n.d. |
68.98s |
104.0 |
94.1 |
3 |
4 |
Negative control |
- |
n.d. |
1.94 |
100 |
100 |
|
|
62.5 |
- |
- |
n.c. |
102.6 |
n.c. |
|
|
125 |
- |
- |
n.c. |
90.9 |
n.c. |
|
|
250 |
- |
- |
1.29 |
102.0 |
125.2 |
|
|
500 |
- |
- |
2.62 |
102.0 |
111.0 |
|
|
1000 |
- |
- |
13.23s |
132.4 |
83.2 |
|
|
1400 |
- |
- |
0.29 |
94.6 |
111.0 |
|
|
Positive Control(1) |
- |
n.d. |
93.00s |
117.9 |
78.6 |
*Macroscopically visible precipitation in culture medium at the end of exposure period |
|||||||
**Mutant frequency MF corr: mutant colonies per 10E6 cells corrected with the CE2 value |
|||||||
***Cloning efficiency related to the respective vehicle control |
|||||||
s Mutant frequency statistically significant higher than corresponding control values |
|||||||
n.c. Culture was not continued since a minimum of only four analyzable concentrations is required |
|||||||
(1) EMS 400 µg/mL |
Table 2: Summary of results- experimental parts with S9 mix
Exp. |
Exposure Period [h] |
Test groups [µg/mL] |
S9 mix |
Prec.* |
Genotoxicity ** MF corr. [per 10E6 cells] |
Cytotoxicity*** CE1 [%] |
Cytotoxicity*** CE2 [%] |
1 |
4 |
Negative control |
+ |
n.d. |
0 |
100 |
100 |
|
|
43.8 |
+ |
- |
1.15 |
108.3 |
77.6 |
|
|
87.5 |
+ |
- |
1.08 |
109.4 |
83.0 |
|
|
175.0 |
+ |
- |
0.00 |
108.9 |
106.0 |
|
|
350.0 |
+ |
- |
0.00 |
103.1 |
99.7 |
|
|
700.0 |
+ |
- |
0.32 |
108.3 |
92.2 |
|
|
1400 |
+ |
- |
0.00 |
106.9 |
85.7 |
|
|
Positive control(2) |
+ |
n.d. |
116.67s |
98.9 |
75.2 |
2 |
4 |
Negative control |
+ |
n.d. |
0.59 |
100 |
100 |
|
|
62.5 |
+ |
- |
n.c. |
99.1 |
n.c. |
|
|
125 |
+ |
- |
0.87 |
89.7 |
101.2 |
|
|
250 |
+ |
- |
3.14 |
104.9 |
93.5 |
|
|
500 |
+ |
- |
0.90 |
117.7 |
98.5 |
|
|
1000 |
+ |
- |
2.00 |
113.7 |
88.2 |
|
|
1400 |
+ |
- |
2.18 |
80.3 |
94.4 |
|
|
Positive Control(2) |
+ |
n.d. |
101.70s |
89.1 |
69.1 |
*Macroscopically visible precipitation in culture medium at the end of exposure period |
|||||||
**Mutant frequency MF corr: mutant colonies per 10E6 cells corrected with the CE2 value |
|||||||
***Cloning efficiency related to the respective vehicle control |
|||||||
s Mutant frequency statistically significant higher than corresponding control values |
|||||||
n.c. Culture was not continued since a minimum of only four analyzable concentrations is required |
|||||||
(2) DMBA 1.25 µg/mL |
Table 1: Summary table – experimental parts without S9 mix
Exp. |
Schedule |
Test groups |
S9 mix |
P* |
Genotoxicity |
Cytotoxicity** |
||||
Exposure/ preparation period |
Aberrant cells [%] |
Polyploid cells [%] |
RPD
[%] |
Mitotic index [%] |
||||||
incl. gaps# |
excl. gaps# |
with exchanges |
||||||||
1 |
4/18 hrs |
Negative control |
- |
n.d. |
7.3 |
5.0 |
2.0 |
1.3 |
100.0 |
100.0 |
350.0 µg/mL |
- |
- |
7.3 |
2.7 |
1.3 |
6.0 |
109.0 |
133.0 |
||
700.0 µg/mL |
- |
- |
8.3 |
3.0 |
0.0 |
2.6 |
104.5 |
111.8 |
||
1400.0 µg/mL |
- |
- |
4.0 |
1.3 |
0.3 |
1.0 |
90.5 |
144.8 |
||
Positive control1 |
- |
n.d. |
8.3 |
4.0 |
1.0 |
3.2 |
n.t. |
141.2
|
||
2 |
4/18 hrs |
Negative control |
- |
n.d. |
8.3 |
3.3 |
0.3 |
0.3 |
100.0 |
100.0 |
350.0 µg/mL |
- |
- |
6.7 |
3.3 |
1.0 |
1.0 |
106.7 |
114.2 |
||
700.0 µg/mL |
- |
- |
9.0 |
2.7 |
0.3 |
1.3 |
104.5 |
130.3 |
||
1400.0 µg/mL |
- |
- |
9.3 |
4.7 |
0.7 |
1.3 |
100.3 |
109.4 |
||
Positive control1 |
- |
n.d. |
14.3 |
10.3S |
4.0 |
0.0 |
n.t. |
128.1
|
||
3 |
18/18 hrs |
Negative control |
- |
n.d. |
9.3 |
5.3 |
1.7 |
0.0 |
100.0 |
100.0 |
87.5 µg/mL |
- |
- |
6.3 |
5.0 |
1.7 |
1.0 |
95.9 |
81.6 |
||
175.0 µg/mL |
- |
- |
5.3 |
2.3 |
1.0 |
2.0 |
96.2 |
97.4 |
||
350.0 µg/mL |
- |
- |
12.3 |
7.7 |
3.7 |
0.0 |
99.4 |
92.9 |
||
700.0 µg/mL |
- |
- |
n.s. |
n.s. |
n.s. |
n.s. |
99.2 |
n.s. |
||
1400.0 µg/mL |
- |
- |
n.s. |
n.s. |
n.s. |
n.s. |
77.0 |
n.s. |
||
Positive control1 |
- |
n.d. |
30.0 |
28.0S |
13.7 |
0.0 |
n.t. |
57.9
|
||
4 |
18/18 hrs |
Negative control |
- |
n.d. |
9.0 |
4.7 |
1.3 |
0.7 |
100.0 |
100.0 |
125.0 µg/mL |
- |
- |
6.3 |
2.0 |
1.0 |
2.0 |
102.4 |
81.9 |
||
250.0 µg/mL |
- |
- |
9.3 |
4.3 |
1.0 |
2.0 |
105.3 |
77.3 |
||
500.0 µg/mL |
- |
- |
8.0 |
4.0 |
0.7 |
2.0 |
101.2 |
79.6 |
||
1000.0 µg/mL |
- |
- |
n.s. |
n.s. |
n.s. |
n.s. |
88.1 |
n.s. |
||
Positive control1 |
- |
n.d. |
18.3 |
13.3S |
6.7 |
0.3 |
n.t. |
75.9 |
* Precipitation determined at the end of exposure period (macroscopic)
** Relative values compared with the respective vehicle control
# Inclusive cells carrying exchanges
n.d. Not determined
n.t. Not tested
n.s. Not scorable due to strong cytotoxicity and/or poor metaphase quality
S Aberration frequency statistically significant higher than corresponding control values
1 EMS 500 μg/mL
2 CPP 0.5 μg/mL
Table 1 continued: Summary table – experimental parts with S9 mix
Exp. |
Schedule |
Test groups |
S9 mix |
P* |
Genotoxicity |
Cytotoxicity** |
||||
Exposure/ preparation period |
Aberrant cells [%] |
Polyploid cells [%] |
RPD
[%] |
Mitotic index [%] |
||||||
incl. gaps# |
excl. gaps# |
with exchanges |
||||||||
1 |
4/18 hrs |
Negative control |
+ |
n.d. |
8.0 |
3.3 |
1.0 |
4.5 |
100.0 |
100.0 |
350.0 µg/mL |
+ |
- |
8.7 |
4.7 |
1.3 |
0.3 |
97.5 |
111.2 |
||
700.0 µg/mL |
+ |
- |
10.3 |
4.7 |
2.0 |
4.8 |
96.3 |
108.0 |
||
1400.0 µg/mL |
+ |
- |
9.0 |
3.3 |
2.0 |
1.0 |
86.2 |
119.6 |
||
Positive control2 |
+ |
n.d. |
39.3
|
31.7S |
12.7 |
0.3 |
n.t. |
65.6 |
||
3 |
4/28 hrs |
Negative control |
+ |
n.d. |
8.3 |
5.7 |
0.3 |
1.6 |
100.0 |
100.0 |
350.0 µg/mL |
+ |
- |
10.3 |
3.0 |
0.3 |
0.3 |
93.7 |
96.4 |
||
700.0 µg/mL |
+ |
- |
9.3 |
5.0 |
1.0 |
1.3 |
91.3 |
68.9 |
||
1400.0 µg/mL |
+ |
- |
10.7 |
6.3 |
1.3 |
1.0 |
88.3 |
91.0 |
||
Positive control2 |
+ |
n.d. |
39.3
|
37.3S |
17.7 |
0.0 |
n.t. |
101.9 |
||
4 |
4/28 hrs |
Negative control+ |
+ |
n.d. |
9.0 |
3.8 |
0.2 |
1.0 |
100.0 |
100.0 |
500.0 µg/mL |
+ |
- |
9.7 |
4.3 |
1.0 |
1.6 |
97.0 |
139.8 |
||
1000.0 µg/mL |
+ |
- |
8.0 |
3.0 |
0.7 |
0.3 |
98.7 |
107.1 |
||
1400.0 µg/mL+ |
+ |
- |
15.2 |
8.2S |
2.5 |
0.3 |
97.3 |
131.4 |
||
Positive control2 |
+ |
n.d. |
22.0
|
15.0S |
5.0 |
0.3 |
n.t. |
175.2 |
||
5 |
4/28 hrs |
Negative control |
+ |
n.d. |
10.7 |
1.7 |
0.3 |
1.6 |
100.0 |
100.0 |
1000.0 µg/mL |
+ |
- |
10.7 |
3.3 |
0.3 |
0.3 |
97.4 |
94.2 |
||
1200.0 µg/mL |
+ |
- |
9.7 |
3.3 |
0.7 |
2.0 |
95.9 |
90.2 |
||
1400.0 µg/mL |
+ |
- |
10.0 |
4.0 |
0.7 |
0.0 |
95.2 |
95.4 |
||
Positive control2 |
+ |
n.d. |
30.7 |
26.7S |
11.3 |
0.3 |
n.t. |
127.4 |
* Precipitation determined at the end of exposure period (macroscopic)
** Relative values compared with the respective vehicle control
# Inclusive cells carrying exchanges
+ Due to inhomogeneous data 600 metaphase cells were scored per test group
n.d. Not determined
n.t. Not tested
n.s. Not scorable due to strong cytotoxicity and/or poor metaphase quality
S Aberration frequency statistically significant higher than corresponding control values
1 EMS 500 μg/mL
2 CPP 0.5 μg/mL
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Mode of Action Analysis / Human Relevance Framework
No further information available.
Additional information
A study according to OECD TG 471 (May 1983) was conducted to assess the in vitro gene mutation potential of the test item in different bacteria strains (TA 1537, TA 1535, TA 98, TA 100 and E. coli WP uvrA). In the preincubation method bacteria were preincubated for 20 min with the test item using concentrations of 20, 100, 500, 2500 and 5000 µg/plate. Water was used as solvent control. Afterwards, bacterial were plates and exposed for 48 to 72 h. In the standard plate test the exposure duration was 48 to 72 hours as well. Incubation was done in the presence and in the absence of a metabolizing system (S9-Mix from Aroclor-1254 treated male rats). A slight decrease of revertants was occasionally observed from 2500 µg/plate onwards. No genotoxicity was observed neither in presence nor absence of S9-mix. The positive controls induced a significant increase in mutation frequency. (BASF AG, 1999).
In another study according to OECD TG 476 (July 2015), the in vitro gene mutation potential of the test substance in mammalian CHO cells was assessed. After seeding, cells were exposed in the first experiment to concentrations of 43.8, 87.5, 175, 350, 700 or 1400 µg/mL with or without S9-mix freshly prepared from Wistar rats. In the second and third experiment concentrations of 62.5, 125, 250, 500, 1000 and 1400 µg/mL were used. As vehicle and negative control, cell culture medium was utilized. After an exposure time of 4 hours, medium was removed and cell were grown in normal cell culture medium for 7 to 9 days, followed by incubation in selection medium for a period of 6 to 7 days. At the end of the selection period, cells were fixed and cloning efficiency was determined. No cytotoxic effects were observed in all experiments and no genotoxicity could be detected neither in the presence nor absence of S9-mix. Positive controls (ethylmethanesulphonate without S9-mix and 7,12-dimethylbenzanthracene with metabolic activation) proved to be valid under the test conditions chosen (BASF SE, 2016).
For the assessment of structural chromosomal aberrations and aneugenic activity, a study according OECD TG 476 was performed in vitro. Five experiments using mammalian V79 cells were performed selecting different exposure times (4 and 18 hours) and sampling times (18 and 28 hours). The highest concentration on all experiments used was 1400 µg/mL. For metabolic activation, liver S9 mix from phenobarbital and beta-naphthoflavone induced rats was used. At least 300 metaphases for each test group were analyzed for chromosomal aberrations. No relevant increase in the frequency of cells containing numerical chromosome aberrations was demonstrated under the experimental conditions described neither in absence nor presence of metabolic activation. Aberration rates slightly exceeding the historical control data range or statistically significant increased values were obtained in single test groups which were considered biologically irrelevant. The increase in the frequencies of structural chromosome aberrations induced by the positive control substances ethylmethanesulphonate and cyclophosphamide clearly demonstrated the sensitivity of the test system and/or the metabolic activity of the S9 mix employed (BASF SE, 2016).
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Based on the available data, the substance is not considered to be classified for genetic toxicity under Regulation (EC) No 1272/2008, as amended for the ninth time in Regulation (EU) No 2016/1179.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.